
YD Bio Limited Ordinary Shares
YDESHealthcare|Biotechnology|TW
$5.97
-1.21 (-16.85%)
DCF Value
$0.12
Cash / Share
$0.09
Ownership Breakdown
2.0%
Float
70.8M
Shares Outstanding
1.4M
Float Shares
Major Holders (2)
Combined: 138.2%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
Insider Trades (29)
Last 4 quarters: 69,660 acquired · 11,498 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Chang Kochi | director | Sep 30, 2026 | OPTION EX. | 3,135 | $0.00 | $0.31 | Form 4 |
| Chang Kochi | director | Sep 30, 2026 | AWARD | 3,135 | — | — | Form 4 |
| Chang Kochi | director | Sep 30, 2026 | OPTION EX. | 3,135 | — | — | Form 4 |
| Lu Shao-Ta | director | Sep 30, 2026 | OPTION EX. | 3,135 | $0.00 | $0.31 | Form 4 |
| Lu Shao-Ta | director | Sep 30, 2026 | AWARD | 3,135 | — | — | Form 4 |
| Lu Shao-Ta | director | Sep 30, 2026 | OPTION EX. | 3,135 | — | — | Form 4 |
| Shen Ethan PhD | director, officer: CEO | Sep 14, 2026 | BUY | 12,700 | $3.85 | $48.9K | Form 4 |
| Shen Ethan PhD | director, officer: CEO | Sep 9, 2026 | BUY | 3,100 | $3.93 | $12.2K | Form 4 |
| Shen Ethan PhD | director, officer: CEO | Sep 4, 2026 | BUY | 18,378 | $3.67 | $67.4K | Form 4 |
| Lu Shao-Ta | director | Jun 30, 2026 | OPTION EX. | 5,749 | $0.00 | $0.57 | Form 4 |
| Lu Shao-Ta | director | Jun 30, 2026 | AWARD | 5,749 | — | — | Form 4 |
| Lu Shao-Ta | director | Jun 30, 2026 | OPTION EX. | 5,749 | — | — | Form 4 |
| Chang Kochi | director | Jun 30, 2026 | OPTION EX. | 5,749 | $0.00 | $0.57 | Form 4 |
| Chang Kochi | director | Jun 30, 2026 | AWARD | 5,749 | — | — | Form 4 |
| Chang Kochi | director | Jun 30, 2026 | OPTION EX. | 5,749 | — | — | Form 4 |
| Lu Shao-Ta | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Lu Shao-Ta | director | Mar 31, 2026 | OPTION EX. | 2,081 | $0.00 | $0.21 | Form 4 |
| Lu Shao-Ta | director | Mar 31, 2026 | AWARD | 2,081 | — | — | Form 4 |
| Lu Shao-Ta | director | Mar 31, 2026 | OPTION EX. | 2,081 | — | — | Form 4 |
| Chang Kochi | director | Mar 31, 2026 | OPTION EX. | 2,081 | $0.00 | $0.21 | Form 4 |
| Chang Kochi | director | Mar 31, 2026 | AWARD | 2,081 | — | — | Form 4 |
| Chang Kochi | director | Mar 31, 2026 | OPTION EX. | 2,081 | — | — | Form 4 |
| Lu Shao-Ta | director: | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Chang Kochi | director: | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Lee Jerry Yin-Chia | director: | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Zhang Bo-Xiang | director, officer: Chief Medical Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Hen Man Edmund | officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Shen Ethan PhD | director, officer: CEO | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Shen Ethan PhD | director, officer: CEO | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |